Leruez-Ville M - Search Results

1

Low prevalence of active parvovirus B19 infection in HIV-infected patients.

Raguin G, Leruez-Ville M, Gregoire V, Deplanche M, Leport C, Morinet F, Vilde JL. Raguin G, et al. Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10):760-2. doi: 10.1007/BF01709261. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9405950

2

Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intravenous immunoglobulin.

Karmochkine M, Oksenhendler E, Leruez-Ville M, Jaccard A, Morinet F, Herson S. Karmochkine M, et al. Am J Hematol. 1995 Nov;50(3):227-8. doi: 10.1002/ajh.2830500319. Am J Hematol. 1995. PMID: 7485092 No abstract available.

3

Polyarteritis nodosa and parvovirus B19.

Leruez-Ville M, Laugé A, Morinet F, Guillevin L, Dény P. Leruez-Ville M, et al. Lancet. 1994 Jul 23;344(8917):263-4. doi: 10.1016/s0140-6736(94)93030-9. Lancet. 1994. PMID: 7913176 No abstract available.

4

Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins.

Palmer P, Pallier C, Leruez-Ville M, Deplanche M, Morinet F. Palmer P, et al. Clin Diagn Lab Immunol. 1996 Mar;3(2):236-8. doi: 10.1128/cdli.3.2.236-238.1996. Clin Diagn Lab Immunol. 1996. PMID: 8991644 Free PMC article.

5

Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.

Leruez-Ville M, Vassias I, Pallier C, Cecille A, Hazan U, Morinet F. Leruez-Ville M, et al. J Gen Virol. 1997 Jan;78 ( Pt 1):215-9. doi: 10.1099/0022-1317-78-1-215. J Gen Virol. 1997. PMID: 9010306

6

Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

Gareus R, Gigler A, Hemauer A, Leruez-Ville M, Morinet F, Wolf H, Modrow S. Gareus R, et al. J Virol. 1998 Jan;72(1):609-16. doi: 10.1128/JVI.72.1.609-616.1998. J Virol. 1998. PMID: 9420265 Free PMC article.

7

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection.

Leruez-Ville M, Minard V, Lacaille F, Buzyn A, Abachin E, Blanche S, Freymuth F, Rouzioux C. Leruez-Ville M, et al. Clin Infect Dis. 2004 Jan 1;38(1):45-52. doi: 10.1086/380450. Epub 2003 Dec 5. Clin Infect Dis. 2004. PMID: 14679447

8

Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection.

Vauloup-Fellous C, Ducroux A, Couloigner V, Marlin S, Picone O, Galimand J, Loundon N, Denoyelle F, Grangeot-Keros L, Leruez-Ville M. Vauloup-Fellous C, et al. J Clin Microbiol. 2007 Nov;45(11):3804-6. doi: 10.1128/JCM.01654-07. Epub 2007 Sep 26. J Clin Microbiol. 2007. PMID: 17898161 Free PMC article.

9

Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection.

Ducroux A, Cherid S, Benachi A, Ville Y, Leruez-Ville M. Ducroux A, et al. J Clin Microbiol. 2008 Jun;46(6):2078-80. doi: 10.1128/JCM.02179-07. Epub 2008 Apr 16. J Clin Microbiol. 2008. PMID: 18417654 Free PMC article.

10

Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.

Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, Mandelbrot L, Tubiana R, Rouzioux C, Leruez-Ville M; French Perinatal Cohort. Guibert G, et al. Clin Infect Dis. 2009 Jun 1;48(11):1516-25. doi: 10.1086/598934. Clin Infect Dis. 2009. PMID: 19388872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters